- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01991002
14/21 Diet-walking in the Park
Prospective Interventional Study of the Impact of 3-step Diet With Complimentary Exercise Program
The scientific literature shows a quantitative relationship between diet combined with physical activity as a long term weight reduction modality and an important factor in weight maintenance.
Primary assumption - the 14/21 diet will have an impact on BMI values, and their long-term maintenance.
Secondary assumption - the 14/21 diet will have a positive impact on anthropomorphic and biochemical markers, on blood pressure, resting heart rate, RMR, and life quality.
Study Overview
Detailed Description
An interventional part for a duration of 56 days and a follow-up period including monitoring of different parameters. Follow up session are set to 3, 6, 12 and 24 months from the end of the interventional period.
Participants will be recruited in several rounds, each including up to 25 participants. Diet program is divided into 3 periods: 1. Low carb diet for 14 days; 2. Low carb and regular diet in alternating days for 21 days; 3. Individual carbohydrate-rich diet for 21 days.
The diet consists of a free choice of food ingredients from a detailed list of foods in each category (proteins, carbohydrates, vegetables, fat etc.). The participants are free to choose the types of food as long as they are within the specified allowance (quantity) for each food group.During the intervention period subjects will meet for walking. In addition, 30 minutes of aerobic exercise will be recommended 3 times/week.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tel Aviv, Israel
- Assuta Medical Centers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Hebrew speaking 25<BMI<30 18 years old or older signed an informed consent
Exclusion Criteria:
Subjects who have a physical disability preventing them from exercise, Subjects who are pregnant or lactating, Subjects who are currently involved in another lifestyle intervention program, Subjects who had undergone bariatric surgery in the past, Subjects with: cancer, liver/kidney disease, organ transplantation, alcohol/drug addiction, Subjects that have cognitive deterioration or psychosis, vegetarians who does't eat fish/sea food or vegans
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 14/21 diet
Diet program is divided into 3 periods: 1. Low carb diet for 14 days; 2. Low carb and regular diet in alternating days for 21 days; 3. Individual carbohydrate-rich diet for 21 days. The diet consists of a free choice of food ingredients from a detailed list of foods in each category (proteins, carbohydrates, vegetables, fat etc.). The participants are free to choose the types of food as long as they are within the specified allowance (quantity) for each food group. |
Diet program is divided into 3 periods: 1. Low carb diet for 14 days; 2. Low carb and regular diet in alternating days for 21 days; 3. Individual carbohydrate-rich diet for 21 days. The diet consists of a free choice of food ingredients from a detailed list of foods in each category (proteins, carbohydrates, vegetables, fat etc.). The participants are free to choose the types of food as long as they are within the specified allowance (quantity) for each food group. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight reduction
Time Frame: 2 years
|
BMI will be calculated by the equation weight divided by square height.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric measurements
Time Frame: 2 years
|
Waist circumference will be measured at the level of the umbilicus.
Hip circumference will be measured at the widest portion of the buttocks.
Waist/hip ratio will be calculated.
"Tanita" will be used for body composition analysis (%fat mass, fat mass,fat free mass and RMR).
|
2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biochemical markers
Time Frame: 2 years
|
To measure glucose, HbA1C (Glycated hemoglobin), blood fat profile, liver enzymes, inflammatory markers.
|
2 years
|
Blood pressure
Time Frame: 2 years
|
Blood pressure will be measured.
|
2 years
|
Quality of life.
Time Frame: 2 years
|
Visual Analog Scale questionnaire and SF-12 questionnaire will be filled out by the subjects.
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Joshua Shemer, Prof., Assuta Hospital Systems
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- diet003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight: 25 <BMI <30
-
University Hospital, MontpellierUnknownBMI Greater Than 30France
-
University Hospital, Clermont-FerrandLaboratory of metabolic adaptation to exercise under Physiological and Physiopathological...UnknownType 2 Diabetes | Postmenopausal Women | Overweight (BMI > 25)France
-
University Hospital, Strasbourg, FranceUnknownCardiac Surgery | Cardiopulmonary Bypass | Obese Patients (BMI ≥ 30 kg/m²)France
-
Lille Catholic UniversityCentre Hospitalier ArrasRecruitingObesity Without Type 2 Diabetes, With BMI>30France
-
University Hospital, Clermont-FerrandUnknown
-
University of California, Los AngelesCompleted160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All EthnicityUnited States
-
Hillel Yaffe Medical CenterUnknownBMI | Lipid Profile
-
Parc de Salut MarNeuroelectrics CorporationCompletedObesity, Morbid | Obesity (BMI > 35) and Diabetes Mellitus | Obesity (BMI > 35) and High Blood Pressure | Obesity (BMI > 35) and Dyslipemia
-
Icahn School of Medicine at Mount SinaiCompletedMorbid Obesity | High BMIUnited States
-
University Hospital, Clermont-FerrandONAPS : Observatoire National de l'Activité Physique et de la SédentaritéUnknownAdolescents (12 to 17 Years Old) | Obese (BMI>90th Percentile)France
Clinical Trials on 14/21 diet
-
Banyan Biomarkers, IncCompleted
-
Tsinghua UniversityNanshan Branch of Qilu HospitalCompletedAutoimmune Diseases | Fatty Liver | Chronic Disease | Fasting | Kidney Stone | Metabolic Disease | High Blood Pressure | Gall Stone | HysteromyomaChina
-
Instituto Nacional de Cardiologia Ignacio ChavezRecruitingRheumatoid Arthritis | Inflammatory Response | Diet, HealthyMexico
-
Rijnstate HospitalActive, not recruitingMorbid Obesity | Bariatric SurgeryNetherlands
-
RAI Services CompanyCompletedSmoking | Tobacco Use | Tobacco Smoking | Smoking BehaviorsUnited States
-
NobelpharmaCompletedCytomegalovirus DiseaseUnited States, Japan
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
Alanya Alaaddin Keykubat UniversityCompletedBenign Paroxysmal VertigoTurkey
-
Perha PharmaceuticalsFondation Jérôme Lejeune; European Innovation Council; France 2030 programRecruitingHealthy Volunteers | Down Syndrome | Alzheimer's DiseaseFrance
-
Ain Shams UniversityNot yet recruiting